CAROTENOID-CONTAINING COMPOSITIONS AND METHODS
The present invention is directed to methods for improving optical or skin health in a subject comprising administering to the subject a combination of lutein, zeaxanthin, lycopene, and beta-carotene.
1 . A method for increasing macular optical density in a subject comprising administering to the subject a combination of lutein, zeaxanthin, lycopene, and beta-carotene.
2 . The method of claim 1 wherein the amount of lutein administered is within the range of about 0.01 mg and about 20 mg per kg body weight per day.
3 . The method of claim 1 wherein the amount of lutein administered is within the range of about 0.1 mg and about 10 mg per kg body weight per day.
4 . The method of claim 1 wherein the amount of zeaxanthin administered is within the range of about 0.01 mg and about 20 mg per kg body weight per day.
5 . The method of claim 1 wherein the amount of zeaxanthin administered is within the range of about 0.1 mg and about 10 mg per kg body weight per day.
6 . The method of claim 1 wherein the amount of lycopene administered is within the range of about 0.01 mg and about 10 mg per kg body weight per day.
7 . The method of claim 1 wherein the amount of lycopene administered is within the range of about 0.1 mg and about 5 mg per kg body weight per day.
8 . The method of claim 1 wherein the amount of beta-carotene administered is within the range of about 0.01 mg and about 10 mg per kg body weight per day.
9 . The method of claim 1 wherein the amount of beta-carotene administered is within the range of about 0.1 mg and about 5 mg per kg body weight per day.
10 . The method of claim 1 wherein the amount of lutein administered is within the range of about 0.1 mg and about 10 mg per kg body weight per day, the amount of zeaxanthin administered is within the range of about 0.1 mg and about 10 mg per kg body weight per day, the amount of lycopene administered is within the range of about 0.1 mg and about 5 mg per kg body weight per day, and the amount of beta-carotene administered is within the range of about 0.1 mg and about 5 mg per kg body weight per day.
11 . The method of claim 1 additionally comprising the administration of at least one LCPUFA.
12 . The method of claim 10 wherein the LCPUFA is selected from the group consisting of DHA, ARA, EPA, and combinations thereof.
13 . The method of claim 1 additionally comprising the administration of at least one prebiotic.
14 . The method of claim 13 wherein the prebiotic comprises a combination of galacto-oligosaccharide and polydextrose.
15 The method of claim 1 wherein the subject is an infant.
16 . A method for increasing retinal pigment epithelial cell density in a subject comprising administering to the subject a combination of lutein, zeaxanthin, lycopene, and beta-carotene.
17 . A method for preventing photoreceptor cell death in a subject comprising administering to the subject a combination of lutein, zeaxanthin, lycopene, and beta-carotene.
18 . A method for improving skin health in a subject comprising administering to the subject a combination of lutein, zeaxanthin, lycopene, and beta-carotene.
19 . The method of claim 18 wherein the improvement in skin health comprises a reduction of erythema or rash.
20 . A method for preventing obesity in a subject comprising administering to the subject a combination of lutein, zeaxanthin, lycopene, and beta-carotene.